Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 17;14(7):717-26.
doi: 10.1038/ncb2522.

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

Long Zhang  1 , FangFang Zhou, Yvette Drabsch, Rui Gao, B Ewa Snaar-Jagalska, Craig Mickanin, Huizhe Huang, Kelly-Ann Sheppard, Jeff A Porter, Chris X Lu, Peter ten Dijke
Affiliations

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

Long Zhang et al. Nat Cell Biol. .

Abstract

The stability and membrane localization of the transforming growth factor-β (TGF-β) type I receptor (TβRI) determines the levels of TGF-β signalling. TβRI is targeted for ubiquitylation-mediated degradation by the SMAD7-SMURF2 complex. Here we performed a genome-wide gain-of-function screen and identified ubiquitin-specific protease (USP) 4 as a strong inducer of TGF-β signalling. USP4 was found to directly interact with TβRI and act as a deubiquitylating enzyme, thereby controlling TβRI levels at the plasma membrane. Depletion of USP4 mitigates TGF-β-induced epithelial to mesenchymal transition and metastasis. Importantly, AKT (also known as protein kinase B), which has been associated with poor prognosis in breast cancer, directly associates with and phosphorylates USP4. AKT-mediated phosphorylation relocates nuclear USP4 to the cytoplasm and membrane and is required for maintaining its protein stability. Moreover, AKT-induced breast cancer cell migration was inhibited by USP4 depletion and TβRI kinase inhibition. Our results uncover USP4 as an important determinant for crosstalk between TGF-β and AKT signalling pathways.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46 - PubMed
    1. Cell. 2010 Feb 5;140(3):384-96 - PubMed
    1. Nat Cell Biol. 2003 May;5(5):410-21 - PubMed
    1. Nature. 1997 Oct 9;389(6651):631-5 - PubMed
    1. Cell Res. 2009 Jan;19(1):21-35 - PubMed

Publication types

MeSH terms

Substances